These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 39055475)

  • 1. Unexpected Cataract Formation Following Valproate Treatment: A Case Report.
    Sinha N; Patil PS; Ananta A; Suresh SB; Unni N
    Cureus; 2024 Jun; 16(6):e63093. PubMed ID: 39055475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Cipriani A; Reid K; Young AH; Macritchie K; Geddes J
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003196. PubMed ID: 24132760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder?
    Haymond J; Ensom MH
    Ther Drug Monit; 2010 Feb; 32(1):19-29. PubMed ID: 19901867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is intravenous valproate more efficacious than oral valproate for inpatients with bipolar I disorder with a manic or depressive episode and concomitant symptoms of opposite polarity?
    Cuomo A; Barillà G; Cattolico M; Carmellini P; Spiti A; Pozza A; Fagiolini A
    Bipolar Disord; 2024 May; 26(3):277-283. PubMed ID: 37957926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium valproate induced acute pancreatitis in a bipolar disorder patient: a case report.
    Huang W; Ren X; Shen F; Xing B
    BMC Pharmacol Toxicol; 2019 Nov; 20(1):71. PubMed ID: 31783774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate for acute mood episodes in bipolar disorder.
    Macritchie K; Geddes JR; Scott J; Haslam D; de Lima M; Goodwin G
    Cochrane Database Syst Rev; 2003; (1):CD004052. PubMed ID: 12535506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and pathophysiological characteristics of valproate-induced pleural effusion.
    Tryfon S; Papadopoulou E; Saroglou M; Vlachopoulos D; Georgopoulou A; Serasli E; Ismailos G
    Clin Toxicol (Phila); 2021 Oct; 59(10):869-876. PubMed ID: 34259092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid reversal of corticosteroid-induced mania with sodium valproate: a case series of 20 patients.
    Roxanas MG; Hunt GE
    Psychosomatics; 2012; 53(6):575-81. PubMed ID: 23157995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate-Induced Hyperammonemic Encephalopathy Causing New-Onset Seizures.
    Sammar A; Tawfik M; Fatima F; Butler A; Aylor-Lee K
    Cureus; 2023 Oct; 15(10):e47288. PubMed ID: 38021840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium valproate induced priapism in an adult with bipolar affective disorder.
    Bansal S; Gupta SK
    Indian J Pharmacol; 2013; 45(6):629-30. PubMed ID: 24347777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
    Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study.
    Brady KT; Sonne SC; Anton R; Ballenger JC
    J Clin Psychiatry; 1995 Mar; 56(3):118-21. PubMed ID: 7883730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An individualized medication model of sodium valproate for patients with bipolar disorder based on machine learning and deep learning techniques.
    Zheng P; Yu Z; Mo L; Zhang Y; Lyu C; Yu Y; Zhang J; Hao X; Wei H; Gao F; Li Y
    Front Pharmacol; 2022; 13():890221. PubMed ID: 36339624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate serum concentrations in patients with hypoalbuminemia and medical complications.
    VandenBerg A; Broadway J; Lalich C; Kennedy R; Williams K
    Ment Health Clin; 2017 Jan; 7(1):13-15. PubMed ID: 29955492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report.
    Patel N; Landry KB; Fargason RE; Birur B
    Psychopharmacol Bull; 2017 Jan; 47(1):40-44. PubMed ID: 28138203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
    Nasrallah HA; Ketter TA; Kalali AH
    J Affect Disord; 2006 Oct; 95(1-3):69-78. PubMed ID: 16780960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U.S. experience with valproate in manic depressive illness: a multicenter trial.
    Brown R
    J Clin Psychiatry; 1989 Mar; 50 Suppl():13-6. PubMed ID: 2494153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
    Langosch JM; Drieling T; Biedermann NC; Born C; Sasse J; Bauer H; Walden J; Bauer M; Grunze H
    J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of Parkinsonian syndrome, cognitive impairment and hyperammonemia induced by divalproate sodium prescribed for bipolar disorder].
    Ricard C; Martin K; Tournier M; Bégaud B; Verdoux H
    Encephale; 2005; 31(1 Pt 1):98-101. PubMed ID: 15971646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.